Publikationen in Zusammenarbeit mit Forschern von Hospital de Jerez (1)

2023

  1. First-Line Versus Second-Line Use of Reslizumab in Severe Uncontrolled Asthma

    Journal of Investigational Allergology and Clinical Immunology